SEARCH RESULTS FOR: "Tag: GILD"
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(2)
ARTICLES/BLOGS
2019(2)
2018(8)
2017(26)
2016(38)
2015(31)
2014(16)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(11)
Analyst Update(16)
Analyst Upgrades(8)
Best and Worst Stocks(1)
Buzz Stocks(9)
By the Numbers(3)
Earnings Preview(5)
Editor's Pick(1)
Expectational Analysis(2)
General(22)
Intraday Option Activity(13)
Market Recap(2)
Midday Market Check(1)
Most Active Options Update(2)
Most Active Weekly Options(2)
Opening View(12)
Quantitative Analysis(1)
Stock Market News(4)
Stocks On the Move(17)
Technical Analysis(1)
The Week Ahead(3)
Trader Content(1)

2/12/2019 9:28 AM
The shares of Gilead Sciences, Inc. (NASDAQ:GILD) are down 3.1% in electronic trading, after the biotech said a late-stage trial for its Non-Alcoholic Steatohepatitis (NASH) drug, selonsertib, failed...
2/5/2019 9:14 AM
U.S. stock futures are modestly higher this morning, though the Nasdaq-100 Index (NDX) is lagging its peers amid concerns about rising costs for Google parent Alphabet (GOOGL) after last night's q...
9/12/2018 9:54 AM
Gilead Sciences, Inc. (NASDAQ:GILD) stock is up 3.9% to trade at $75.04 this morning, after the biotech name's rheumatoid arthritis drug filgotinib met its primary goals in a late-stage study. The tre...
8/15/2018 3:03 PM
Stocks are getting clobbered today, dragged down by declining FAANG stocks and oil prices. Looking at individual names, electric vehicle maker Tesla Inc (NASDAQ:TSLA), weight loss concern Weight Wat...
7/26/2018 9:53 AM
Shares of Gilead Sciences, Inc. (NASDAQ:GILD) are lower in early trading after the company last night announced that both CEO John Milligan and Chairman John Martin will step down by year's end. On t...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center